Renal transplant Clinical Trials

3 recruiting

About Renal transplant Clinical Trials

Looking for clinical trials for Renal transplant? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Renal transplant trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Renal transplant clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 119 of 19 trials

Recruiting
Phase 4

Semaglutide Treatment for Hyperglycaemia After Renal Transplantation

DiabetesHyperglycemiaRenal Transplant Complication Primary Non-Function
Rigshospitalet, Denmark104 enrolled1 locationNCT05702931
Recruiting
Not Applicable

The Effect of Emotion-Focused Intervention on Emotion Regulation and Well-Being of Individuals With Transplantation

Renal Transplantation
Akdeniz University56 enrolled1 locationNCT07294183
Recruiting
Phase 1Phase 2

Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor

Kidney TransplantToleranceRenal Transplant Rejection
Jeffrey Veale, MD15 enrolled1 locationNCT03707262
Recruiting
Phase 1

Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study

Chronic Kidney DiseasesRenal Transplantation
Qianfoshan Hospital30 enrolled1 locationNCT07045467
Recruiting

Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients

Acute Kidney InjuryRenal Transplantation
Assistance Publique - Hôpitaux de Paris30 enrolled1 locationNCT06026592
Recruiting
Not Applicable

Evaluation of the Efficacy of Dd-cfDNA in Routine Patient Care in Kidney Transplant Recipients"

Renal Transplantation
Assistance Publique - Hôpitaux de Paris500 enrolled6 locationsNCT06406179
Recruiting

Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection

Graft FailureAcute Rejection of Renal Transplant
Loma Linda University150 enrolled1 locationNCT05084768
Recruiting

Multimodal Ultrasound in DBD Kidneys for Predicting Early Postoperative Renal Insufficiency Risk

Occurrence of Renal Dysfunction (GFR ≤ 60mL/(Min·1.73m2)) in Renal Transplant Recipients Within One Year After Kidney Transplantation
Bei Wang27 enrolled1 locationNCT07090512
Recruiting

Validity and Reliability of 6 Minute Stepper Test in Kidney Transplant Recipients

Renal Transplanted Recipients
Hacettepe University40 enrolled1 locationNCT06707792
Recruiting

Knowledge of Cardiovascular Risk Factors in Chronic Kidney Disease Patients

Chronic Kidney Disease(CKD)Renal Transplantation
Hacettepe University28 enrolled1 locationNCT06674031
Recruiting

Muscle Oxygenation, Functional Capacity and Frailty in Kidney Transplant Recipients with and Without Inspiratory Muscle Weakness

Renal Transplantation
Hacettepe University30 enrolled1 locationNCT06706492
Recruiting

Exercise Capacity in Kidney Transplant Recipients

Renal Transplantation
Hacettepe University27 enrolled1 locationNCT06706154
Recruiting
Phase 4

Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients

Disorder Related to Renal Transplantation
University of Sao Paulo General Hospital80 enrolled1 locationNCT06584773
Recruiting

Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients

DiagnosisKidney Transplant; ComplicationsKidney Transplant+4 more
Liverpool University Hospitals NHS Foundation Trust282 enrolled1 locationNCT06025240
Recruiting
Phase 2

Combined Kidney and Hematopoietic Stem Cell Transplantation for Tolerance Induction

Renal Transplantation
Rabin Medical Center20 enrolled1 locationNCT05086003
Recruiting

Queensland Renal Biopsy Registry

Renal transplantRenal Biopsy RegistryAcute Kidney Injury+1 more
Associate Professor Sree Krishna Venuthurupalli on behalf of Steering Committee , Queensland Renal Biopsy Registry5,000 enrolled11 locationsACTRN12619001030167
Recruiting
Phase 4

Cytomegalovirus-specific immune monitoring to guide pre-emptive therapy surveillance protocol for prevention of cytomegalovirus infection after renal transplantation.

Cytomegalovirus infection after renal transplantation
associate Prof. Tomas Reischig, M.D., Ph.D.150 enrolled1 locationACTRN12618000913279
Recruiting
Phase 3

Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients.

Post transplant anaemia in renal transplant recipients.
Princess Alexandra hospital (Department of nephrology)100 enrolled1 locationACTRN12608000186358
Recruiting
Phase 3

Effects of antioxidant supplementation with Astaxanthin on blood vessels in renal transplant patients

Vascular DysfunctionRenal Transplantation
Launceston General Hospital44 enrolled1 locationACTRN12608000159358